Human Longevity Expands $1M Cancer Pledge to Include Colon Cancer
The biotechnology company's integrated screening approach combines whole-genome sequencing, imaging, and multiple biomarker tests to enable early detection.
Latest Articles
Editor's Top Picks
What Clinical Lab Leaders Predict for 2026
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
BD Expands BD Max System Menu with IVDR-Certified Viasure Assays
Partnership with Certest Biotec adds respiratory and STI molecular diagnostic panels for European laboratories.
Equipment & Supply Spotlight
Co-Diagnostics to Present Portable PCR Platform with AI Integration
The presentation introduces the Co-Dx PCR platform and smartphone interface and discusses how Co-Dx is harnessing AI to minimize user error and improve outcomes in real-time point-of-care testing.
News, Know-How & Standards
Disease Detection & Understanding
Why Cervical Cancer Screening Rates Are Falling—and What Could Help Reverse the Trend
Despite effective prevention tools, Millennials are delaying screening. New approaches may help remove barriers to participation.
